Hepatitis B pp 137-147 | Cite as

The Development of the Hepatitis B Vaccine

  • Irving Millman

Abstract

In the October 9, 1980 issue of The New England Journal of Medicine Szmuness et al. published the results of a clinical trial. This trial assessed the efficacy of an inactivated hepatitis B vaccine (produced by Merck) in a placebo controlled, randomized, double blind trial in 1083 homosexual men at high risk for hepatitis B virus infection. Within the limits of the studies that have been reported, the vaccine was found to be safe; the incidence of side effects was low. After a third dose was administered, 96% of those who received the vaccine developed antibodies against HBsAg and none of the individuals who developed antibodies had a hepatitis episode. The results of this trial were discussed at the 1981 International Symposium on Viral Hepatitis in New York City March 30 through April 2, 1981, and celebrations appeared to be in order for the first hepatitis B vaccine to be placed on the market.

Keywords

Surface Antigen Infectious Hepatitis Virus Cesium Chloride Foreign Patent Australia Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blumberg, B. S., Gerstley, B. J., Hungerford, D. A., London, W. T., and Sutnick, A. I. (1967). Ann. Intern. Med. 66:924.CrossRefGoogle Scholar
  2. 2.
    Bayer, M. E., Blumberg, B. S., and Werner, B. (1968). Nature 218:1057.PubMedCrossRefGoogle Scholar
  3. 3.
    Coyne, V. E., Blumberg, B. S., and Millman, I. (1971). Proc. Soc. Exp. Biol. Med. 138:1051.PubMedCrossRefGoogle Scholar
  4. 4.
    Okochi, K. and Murakami. S. (1968). Vox Sang. 15:374.PubMedCrossRefGoogle Scholar
  5. 5.
    Okochi, K., Murakami, S., Ninomiya, M., and Kaneko, M. (1970). Vox Sang. 18:289.CrossRefGoogle Scholar
  6. 6.
    Blumberg, B. S., Sutnick, A. I., London, W. T., and Millman, I. (1971). Critical Reviews in Clinical Laboratory Sciences, Vol. 2, issue 3. Australia Antigen and Hepatitis. A Comprehensive Review, p. 32.Google Scholar
  7. 7.
    Lichter, A. E. (1969). Nature 224:810.PubMedCrossRefGoogle Scholar
  8. 8.
    Hirschman, R. J., Shulman, N. R., Barker, L. F., and Smith, K. O. (1969). JAMA 108:1667.CrossRefGoogle Scholar
  9. 9.
    London, W. T., Millman, I., Sutnick, A. I., and Blumberg, B. S. (1970). Clin. Res. 18:536.Google Scholar
  10. 10.
    London, W. T. (1970). Proc. Natl. Acad. Sci. USA 66:235.Google Scholar
  11. 11.
    London, W. T. and Blumberg, B. S. (1973). Symposium IVth Int. Cong. Primat. 4:30.Google Scholar
  12. 12.
    Krugman, S., Giles, J. P., and Hammond, J. (1967). JAMA 200:365.PubMedCrossRefGoogle Scholar
  13. 13.
    Krugman, S., Giles, J. P., and Hammond, J. (1970). J. Infec. Dis. 122:432.CrossRefGoogle Scholar
  14. 14.
    Soulier, J. P., Blatix, C., and Courouce, A. M. (1972). Am. J. Dis. Child. 123:429.PubMedGoogle Scholar
  15. 15.
    Purcell, R. H. and Gerin, J. L. (1975). Am. J. Med. Sci. 270:395.PubMedCrossRefGoogle Scholar
  16. 16.
    Hilleman, M. R., Buynak, E. B., and Roehm, R. R. (1975). In Proceedings of a Symposium on Viral Hepatitis, National Academy of Sciences, Washington, D.C., March 17–19, 1975.Google Scholar
  17. 17.
    Buynak, E. B., Roehm, R. R., Tytell, A. A., Bertland, A. U., Lampson, G. P., and Hilleman, M. R. (1976). Proc. Soc. Exp. Biol. Med. 151:694.PubMedCrossRefGoogle Scholar
  18. 18.
    Murphy, B. L., Maynard, J. E., and LeBouvier, G. L. (1974). Intervirol. 3:378.CrossRefGoogle Scholar
  19. 19.
    Barker, L. F., Gerety, R. J., Hoofnagle, J. H., and Nortman, D. F. (1974). In Transmissible Disease and Blood Transfusion, 6th Am. Red Cross Scientific Symp., Washington, D. C., T. J. Greenwalt and D. Q. Jamieson, eds.Google Scholar
  20. 20.
    Maupas, P., Coursaget, P., Goudeau, A., and Drucker, J. (1976). Lancet 1:1367.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Irving Millman
    • 1
  1. 1.Institute for Cancer ResearchFox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations